Showing 1771-1780 of 2839 results for "".
- Cartessa Aesthetics Introduces Helix by DEKAhttps://modernaesthetics.com/news/cartessa-aesthetics-introduces-helix-by-deka/2473418/Cartessa Aesthetics is rolling out Helix by DEKA, a fractional ablative CO2 and non-ablative technologies in one device. The US is the first market to make HELIX commercially available. HELIX features pulse shape control for CoolPeel treatment and adds a 1570nm fiber lase
- FDA Approves Skinvive by Juvéderm to Improve Skin Smoothness in Cheekshttps://modernaesthetics.com/news/fda-approves-skinvive-by-juvederm-to-improve-skin-smoothness-in-cheeks/2473415/The U.S. Food and Drug Administration gave its nod to Skinvive by Juvéderm to improve skin smoothness of the cheeks in adults over the age of 21. Skinvive by Juvéderm is the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin smoothness availabl
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- Dr. Shiv Sabesan Named CTO at Cytrellishttps://modernaesthetics.com/news/dr-shiv-sabesan-named-cto-at-cytrellis/2473409/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- TAKE 5 WITH PETER KANG, CEO, COOLHEALTHhttps://modernaesthetics.com/news/take-5-with-peter-kang-ceo-coolhealth/2473406/Peter Kang, CEO of CoolHealth, chatted with Modern Aesthetics® magazine about the company and their first launch. TargetCool, a cooling device that takes cooling to the next level, provides temporary analgesia to the skin before aesthetic injections including fillers, neuromodulators, and pla
- FDA Clears Renuvion APR Handpiece for Coagulation of Subcutaneous Soft Tissues after Liposuction for Body Contouringhttps://modernaesthetics.com/news/fda-clears-renuvion-apr-handpiece-for-coagulation-of-subcutaneous-soft-tissues-after-liposuction-for-body-contouring/2473404/The U.S. Food and Drug Administration (FDA) cleared the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring. “The Renuvion APR handpiece is the only device to have a 510(k)
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Sculptra Scores FDA Nod for Cheek Wrinkleshttps://modernaesthetics.com/news/sculptra-scores-fda-nod-for-cheeks/2473402/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen produ